Dietary habits are associated with dementia risk in patients with Alzheimer’s pathology
1. Greater adherence to a dietary pattern with lower inflammatory potential was associated with lower dementia risk among individuals with ...
Tag: Alzheimer’s
2 Minute Medicine Rewind June 29, 2026
Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology 1. Greater adherence to a dietary pattern with lower ...
α-synuclein pathology is associated with faster tau accumulation in women
1. α-synuclein pathology was associated with faster tau accumulation in women than men. Evidence Rating Level: 2 (Good) Sex differences ...
Shingles vaccine and sildenafil linked to lower Alzheimer’s risk
1. An expert panel identified the shingles vaccine and sildenafil as the top candidates for repurposing to protect against Alzheimer's ...
2 Minute Medicine Rewind March 9, 2026
Sex-Specific Associations of α-Synuclein Pathology With Tau Accumulation 1. α-synuclein pathology was associated with faster tau accumulation in women than ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
Merck and Mayo Clinic launch AI-driven precision medicine partnership Merck and Mayo Clinic have officially kicked off a landmark R&D ...
Federal Drug Administration approves Alzheimer’s blood test for use in primary care
1. The FDA has cleared the first Alzheimer’s blood test for community use, marking a pivotal step toward earlier and ...
The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. FDA ...
Leqembi gains at home injection for maintenance dosing
1. The FDA cleared a subcutaneous maintenance version of lecanemab, allowing patients with AD (Alzheimer’s disease) to continue treatment at ...
2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
Novo’s srRNA push expands cardiometabolic pipeline On August 28, Novo Nordisk announced a collaboration with Replicate Bioscience to pursue self ...
